Long Term Analytical Validation Study Further Confirms BluePrint as a Reliable Genomic Profiling Assay for Early Stage Breast Cancer Patients
PRESS RELEASE IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS – Read More
PRESS RELEASE IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS – Read More
As a valued customer we wanted to reach out and Read More
AUTHORS: Robert Maganini, Pond Kelemen, Jennifer A. Crozier, Gordan Srkalovic, Read More
PUBLICATION: Soliman et al. BMC Cancer (2020) 20:81 AUTHORS: Hatem Read More
PRESS RELEASE Laura van ’t Veer, PhD, Co-Inventor of MammaPrint, Read More
PRESS RELEASE Laura van ’t Veer, PhD, Co-Inventor of MammaPrint, Read More
PRESS RELEASE Breast Cancer Patients in Germany Now have Insurance Read More
PRESS RELEASE New Data Compare Genomic Profiling Results for Premenopausal Read More
AUTHORS: Lorenza Mittempergher, Joseph McKelley, Rajith Bhaskaran, Sahra Uygun, René Read More
AUTHORS: Jennifer Crozier, Gordan Srkalovic, Adam Brufsky, Mehran Habibi, Pat Read More